Guinea pigs immunized with hepatitis B $urface antigen (HB5Ag). types adu and ayw, and with two polypeptides (40,000 and 24,000 molecular weight) developed cell-mediated immunity (CMI), as determined by the macrophage inhibition assay, and humoral immunity, as determined by radioimmunoassay. Peritoneal exudate (PE) cells from guinea pigs immunized with the 40,000-molecular-weight polypeptide migrated poorly (30 to 88%> inhibition) after challenge with the immunizing subunit or with purif'ied HB.Ag, type adu or ayw.
were predictable and showed a reasonable degree of correlation with the CMI response. PE cells from control animals inoculated with normal human serum or polyacrylamide gel were not inhibited af'ter challenge with purified preparations of HB.Ag or with the 40,000-molecular-weight polypeptide, but did show CMI with their respective immunogens. In addition, PE cells f'rom guinea pigs inoculated with normal human serum were inhibited f'rom migrating after challenge with the 24,000-molecular-weight subunit, suggesting that the latter may contain an antigenic determinant related to a human serum protein.
Hepatitis B is a serious public health problem of international concern which is associated with significant morbidity and mortality. It is particularly prevalent among certain high-risk populations. These groups include individuals who have recently received blood transfusions, users of illicit drugs, homosexuals, health care personnel (surgeons, physicians, dentists, nurses, laboratory technicians, plasmaphoresis, and blood bank staff), hemodialysis patients And their contacts, offspring of mothers who become infected in the last trimester of pregnancy, and residents of crowded institutions. Thus, the need for development of a suitable vaccine is evident.
Efforts in vaccine development, hampered bv an inability to grow hepatitis B virus in tissue and organ cultures, have been directed towards use of modified hepatitis B surface antigen (HB8Ag) preparations. Plasma from persistently infected carriers contains an abundance of' the small 20-nm spherical particles which, after purification, are free of' detectable nucleic acid ' 
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Recent evidence suggests that not only humoral but also cell-mediated immunity plays a role in preventing or aborting hepatitis B infection (6, 9, 19) . In this paper we report the measurement of cell-mediated immunity to HB8Ag and to HB8Ag-derived polypeptides using a migration inhibition assay.
MATERIALS AND METHODS
Purification and isolation of HB,Ag polypeptides. Spherical, 20 ± 2-nm particles containing HB.Ag were purified from human serum as previously described (7) with slight modifications (12) . Briefly, the particles were pelleted for 15 h at 100,000 x g and 4 C, resuspended in saline, and repelleted for 5 h at 200,000 x g and 4 C. The resulting pellet was acidified to pH 2.4 with 0.05 M potassium phthalate-hydrochloride buffer, incubated for 1 h at room temperature, and then twice banded in CsCl at 286,000 x g and 4 C for 18 h. The second isopycnic density centrifugation was followed by a rate-zonal centrifugation for 4 h at 286,000 x g and 4 C in a preformed 5 to 35% (wt/wt) CsCl gradient.
After extensive dialysis against physiological saline to remove the CsCl, the purified antigen was sterilized by filtration through a 0.22-tim cellulose acetate filter.
Polypeptides of purified HB8Ag were prepared by disc polyacrylamide gel electrophoresis as described in detail by this laboratory (3, 6a) and lyophilized. Briefly, the antigen-containing particles were solubilized by heating at 60 C for 10 min in the presence of 6 M urea, 1% sodium dodecyl sulfate, and 1% 2-mercaptoethanol. The subunits were initially fractionated in a preparative polyacrylamide gel electrophoresis apparatus (Buchler Instruments, Fort Lee, N.J.) using a 13.2% separating gel. After elution, the fractions were divided into six pools and refractionated by analytical polyacrylamide gel electrophoresis. The polypeptide products were detected by staining with Coomassie brilliant blue or by scanning the unstained gel in a Gilford gel scanner. Molecular weights of each polypeptide were estimated by comparing distances migrated to that observed using a series of known molecular weight markers. We selected the 24,000-and 40,000-molecular-weight subunits for this study. The smaller-molecular-weight polypeptide has been characterized as a glycoprotein (4 Staphylococcal protein A (Sigma, St. Louis, Mo.) was added to each tube and incubation was continued for 30 min at room temperature. The pellets were washed twice by centrifugation with phosphate-buffered saline and residual radioactivity was determined in an auto-gamma counter. A specimen was considered to be positive if the counts per minute exceeded 2.0 times the mean of a panel of normal guinea pig sera which were negative for anti-HB,.
Cell-mediated immunity assays. Cell-mediated immunity was measured in vitro by the macrophage inhibition assay (1, 5, 14) . In these experiments, immunized guinea pigs were inoculated intraperitoneally with 30 ml of sterile paraffin oil. After 3 days the animals were anesthetized with ether and exsanguinated by cardiac puncture. A midline abdominal incision was made and several 50-ml aliquots of ice-cold (6 to 10 C) Hanks solution containing 0.075% NaHCO3 and 0.5 units of heparin per ml were introduced into the peritoneal cavity, and the abdominal contents were gently mixed. Peritoneal fluid rich in mononuclear cells was aspirated and pooled in 250-ml centrifuge bottles kept in an ice bath. The fluid was centrifuged at 900 rpm for 15 min and the oil and liquid phases were discarded. The peritoneal exudate (PE) cells were resuspended in 2 ml of Hanks medium (4 C) containing 0.075% NaHCO3 and were transferred to a 15-ml centrifuge tube. After washing the cells twice in this same medium, they were resuspended to approximately 10% by volume in Eagle minimal essential medium containing penicillin/streptomycin and 15% heat-inactivated normal guinea pig serum. Cells were counted and the concentration was adjusted to 107 cells/ml.
Equal volumes (0.4 ml) of cells and medium (with and without antigen) were placed in culture tubes (12 by 75 mm) and allowed to interact for 30 min at room temperature. After this incubation period, the suspensions were centrifuged at 200 x g and 4 C for 5 min, and 0. From these preliminary data, we concluded that the optimal immunization schedule was the administration of the immunogen in two equally divided doses at 14-day intervals with subsequent measurement of cell-mediated immunity on day 28. A similar observation was made in other studies in which delayed cutaneous hypersensitivity was evaluated (unpublished data).
Cellular immunity. Cell-mediated immunity in guinea pigs was measured by the macrophage inhibition assay. Guinea pigs were immunized (i) with purified 20 + 2-nm particles containing type-specif'ic aduw or avw HB8Ag, (ii) with the 40,000-or 24,000-molecular-weight polypeptides derived from HB8Ag/adw, (iii) with NHS, or (iv) with PAG. The results are summarized in Table 3 .
PE cells obtained from four guinea pigs inoculated with the 40,000-molecular-weight polypeptide and challenged with the same antigen exhibited a 35 to 88% decrease in macrophage migration. Inhibition ranging from 49 to 58% was observed when the same cells were challenged with purified HB.Ag/adw. Correspondingly, macrophages from three of the four animals were inhibited from migrating when challenged with purified HB8Ag/ayw, and PE cells from the fourth guinea pig showed 14% inhibition. In contrast, significant inhibition of macrophage migration above 20% was observed in only one guinea pig (no. 9) when the same PE cells were challenged with the 24,000-molecular-weight polypeptide preparation. Macrophages from two other guinea pigs were inhib- ited at a level slightly below our arbitrary cut-off value of 20%. Mononuclear cells obtained from three additional animals immunized with the 24,000-molecular-weight polypeptide were inhibited 22, 57, and 95% when challenged with the same polypeptide preparation. Furthermore, cells from two of these animals (no. 13 and 18) exhibited evidence for cell-mediated immunity to the 40,000-molecular-weight subunit and to the purified whole particle containing HB.Ag/ adw. PE cells procured from one animal, guinea pig no. 13, were inhibited 52% after challenge with HB,Ag/ayw, implying a certain degree of type specificity to this polypeptide preparation (6a) .
Guinea pigs inoculated with purified particles containing HB8Ag/adw exhibited evidence for the development of delayed hypersensitivity when their PE cells were challenged with HB.Ag/adw or with the 40,000-molecularweight subunit. PE cells from one of the guinea pigs were inhibited by the 24,000-molecularweight polypeptide, whereas those from the other animal were responsive to HB.Ag/ayw.
A positive inhibitory response to homologous protein was observed with macrophages from guinea pigs sensitized to HB8Ag/ayw. However, cells from only one animal (no. 6) responded to the 40,000-molecular-weight subunit (derived from HB.Ag/adw) and to the whole particle containing HB.Ag/adw. Neither animal exhibited cell-mediated immunity to the 24,000-molecular-weight polypeptide.
Migration of PE cells was significantly inhibited (69%) in animals inoculated and subsequently challenged with PAG (data not shown).
Minimal to absent inhibition was observed among guinea pigs challenged with the two polypeptides or with the whole particles. When PAG was used to challenge PE cells from the other groups of guinea pigs, no inhibition was observed. Significant macrophage inhibition was observed in guinea pigs inoculated and challenged with 1.4 or 140 qg of NHS. In addition, macrophage migration was inhibited 13 and 26%, respectively, when challenged with the 24,000-molecular-weight polypeptide. It is noteworthy that mononuclear cells from one of two guinea pigs inoculated with the 24,000-molecular-weight polypeptide were inhibited 97% after challenge with 100 ,g of NHS (data not shown), whereas none of the other groups of guinea pigs exhibited such evidence of delayed hypersensitivity to this protein. Figure 1 12, 1975 on October These subunits retain specific HB8 antigenic determinants (8, 17) and are highly immunogenic in experimental animals (6a). Two glycosphingolipids also have been extracted (18) and, together with the glycoproteins, may be major contributors of the antigenic activity observed with the whole particles. In vitro and in vivo measurements of cellmediated immunity to intact HB.Ag in guinea pigs have been reported previously (13, 20) . Our findings indicate that guinea pigs inoculated with a 24,000-or 40,000-molecular-weight polypeptide derived from HB8Ag/adw developed cell-mediated and humoral immunity. Animals inoculated with the 40,000-molecular-weight subunit developed antibodies to HB8Ag/adw which were higher than those detected in animals inoculated with the 24,000-molecularweight fragment. Two of four animals inoculated with the larger polypeptide demonstrated high levels of antibody to HB.Ag/ayw. In contrast, a heterologous antibody response to HB.Ag/ayw did not occur in animals injected with the 24,000-molecular-weight preparation. PE cells from guinea pigs inoculated with the 40,000-molecular-weight polypeptide revealed in vitro evidence of cell-mediated immunity after challenge with the homologous antigen or with purified 20-nm particles containing HB.Ag, types adw and ayw. Mononuclear cells from animals sensitized with the 24,000-molecular-weight polypeptide responded to this subunit and, in two of three cases, to both HB.Ag/adw and to the 40,000-molecular-weight subunit. The poor cellular immune response to HB.Ag/avw paralleled the inadequate humoral antibody response observed with the same typespecific antigen. Thus, it appears that the 40,000-molecular-weight polypeptide induces higher humoral and cell-mediated responses to the homologous type-specific HB8Ag than does the 24,000-molecular-weight preparation. Furthermore, the larger subunit induced significantly greater humoral and cell-mediated responses to the heterologous ayw type-specific HBSAg.
It is noteworthy that PE cells from animals immunized with NHS showed no inhibition of migration when challenged with purified preparations of HB.Ag or the 40,000-molecularweight subunit, but were significantly inhibited when challenged with the 24,000-molecularweight polypeptide. A similar cross-reaction was observed in one of two guinea pigs immunized with the 24,000-molecular-weight preparation and challenged with NHS. These results suggest that the 24,000-molecular-weight subunit may contain one or more antigenic determinants related to certain constituents of NHS similar to that recently reported for the whole particle (15, 16) .
